All SEC Filings :: Ligand Pharmaceuticals Incorporated (LGND)

All SEC Filings

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
02/22/23	8-K	Current report filing Related Documents EX-99.1			14
02/17/23	4	Statement of changes in beneficial ownership of securities			1
02/17/23	4	Statement of changes in beneficial ownership of securities			1
02/10/23	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
02/09/23	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Related Documents EX-99.1			7
02/09/23	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			3
02/09/23	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			4
02/06/23	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			3
01/26/23	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
01/20/23	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5